Romanian journal of anaesthesia and intensive care最新文献

{"title":"The Impact of Anaesthesia on Hyperalgesia, Testosterone, Cortisol, C-Reactive Protein, and Glucose Levels After Spine Surgery: Prospective Randomised Controlled Trial","authors":"M. Barsa, O. Filyk","doi":"10.2478/rjaic-2023-0005","DOIUrl":"https://doi.org/10.2478/rjaic-2023-0005","url":null,"abstract":"Abstract Background A large number of spinal deformities with severe pain are treated with complex and traumatic spinal surgeries. The objectives of our study were to test the hypotheses that bilateral erector spinae plane block (BESPB) as a component of combined anaesthesia for spinal surgeries decreases the quantity of opioid analgesic used and reduces hyperalgesia in comparison with general anaesthesia. We additionally proposed the use of serum testosterone, cortisol, C-reactive protein (CRP), and glucose levels as laboratory markers for hyperalgesia. Methods Fifty-two patients who underwent posterior transpedicular fixation of the spine were randomly assigned to either general anaesthesia – control group (CG) – or combined anaesthesia with BESPB – study group (SG). The main outcomes sought were quantity of opioid analgesic perioperatively; hyperalgesia measured with mechanical pain thresholds; and testosterone, cortisol, CRP, and glucose serum levels before and after surgery. Results The quantity of fentanyl and morphine was lower in SG in comparison with CG. There was no difference in mechanical pain thresholds in the SG cohort as opposed to CG, where mechanical pain thresholds were lower on the fifth day after surgery. No difference was found before and after surgery in testosterone, cortisol, CRP, and glucose levels in SG. In the CG, the level of testosterone was significantly lower than baseline; the levels of cortisol, CRP, and glucose were significantly higher than baseline on the fifth day after surgery. Conclusion Bilateral erector spinae plane block as a component of combined anaesthesia for spinal surgeries reduces the quantity of opioid analgesic used and hyperalgesia. Also, we can propose to use the serum testosterone, cortisol, CRP, and glucose levels as the laboratory markers of hyperalgesia.","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"0 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47195806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pyroglutamic Acidosis - An Underrecognised Entity Associated with Acetaminophen Use.","authors":"Wincy Wing-Sze Ng,&nbsp;Hok-Fung Tong,&nbsp;Wai-Yan Ng,&nbsp;Joshua Ka-Ho Yeung,&nbsp;Joyce Kit-Yu Young,&nbsp;Raymond Kam-Wing Woo,&nbsp;Maureen Mo-Lin Wong","doi":"10.2478/rjaic-2023-0004","DOIUrl":"https://doi.org/10.2478/rjaic-2023-0004","url":null,"abstract":"<p><p>Pyroglutamic acidosis (PGA) is an underrecognized entity characterised by raised anion gap metabolic acidosis (RAGMA) and urinary hyper-excretion of pyroglutamic acid. It is frequently associated with chronic acetaminophen (APAP) ingestion. We report the case of a 73-year-old man with invasive pulmonary aspergillosis treated with voriconazole and APAP for analgesia with a cumulative dose of 160 g over 40 days. PGA was suspected as he developed severe RAGMA and common causes were excluded. Diagnosis was confirmed via urinary organic acid analysis which showed significant hyper-excretion of pyroglutamic acid. APAP was discontinued, and N-acetylcysteine (NAC) was administered. His RAGMA rapidly resolved following treatment.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"30 1","pages":"26-30"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/c6/rjaic-30-1-rjaic-2023-0004.PMC10448446.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10481847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevention of Pneumonia due to Ventilator in Critical Patients with U Shape Oral Hygiene Model: A Systematic Review.","authors":"Nova Maryani,&nbsp;Alfini Octavia,&nbsp;Cahyo Budiyantoro,&nbsp;Maria Ulfa","doi":"10.2478/rjaic-2023-0001","DOIUrl":"https://doi.org/10.2478/rjaic-2023-0001","url":null,"abstract":"<p><p>In critical patients, generally, microorganisms originating from nasal cause Ventilator-Associated Pneumonia (VAP). This systematic review was aimed to identify the toothbrush U shape model usage, in potentially decrease the prevalence of ventilator-associated pneumonia among patients in intensive care units. Search strategy identified 15 potentially eligible articles, were 7 RCTs, 4 Meta-analysis, and 4 Observational studies. A total of 15 studies demonstrated the use of toothbrushing and chlorhexidine in mechanically ventilator patients in preventing VAP. Ten studies found positive association between toothbrushing and the use of chlorhexidine in preventing VAP. However, there were 5 studies that did not reveal an additional decrease of VAP incidence either of CHX and only toothbrushing or combination thereof. We cautiously assumed that toothbrushing and chlorhexidine might reduce VAP but the implementation of brushing should be taken into reconsideration in the terms of maintaining it.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"30 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/2a/rjaic-30-1-rjaic-2023-0001.PMC10448447.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10481842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Randomised Controlled Study Comparing Pulse Pressure Variation (PPV) and Pleth Variability Index (PVI) for Goal-Directed Fluid Therapy Intraoperatively in Patients Undergoing Intracranial (Supratentorial ICSOLs) Surgeries.","authors":"Pratyasa Nayak,&nbsp;Subrata Kumar Singha,&nbsp;Monica Khetrapal,&nbsp;Anil Sharma","doi":"10.2478/rjaic-2023-0003","DOIUrl":"https://doi.org/10.2478/rjaic-2023-0003","url":null,"abstract":"<p><p>Fluid management in the perioperative period is a grey zone in clinical practice of late. Looking back on previous practices, static parameters were the only options. Now, dynamic parameters indicating fluid responsiveness have become a significant part of goal-directed fluid therapy (GDFT). However, the efficacy of this approach has yet to be established in neurosurgery cases where patients are already on lot of diuretics, thus making fluid management more challenging. The present study aims to determine the efficacy of the Pleth Variability Index (PVI) with pulse pressure variation (PPV) in guiding GDFT in patients undergoing neurosurgery for supra-tentorial intracranial space occupying lesions (ICSOLs), in the form of a randomised controlled trial. After randomisation, the patients were categorised into either PVI or PPV groups. Both received a baseline 2 ml/kg/h Lactated Ringer's (RL) infusion. Additional fluid boluses consisted of 250 ml of colloid infused over a 10 min period if PVI was > 15% or PPV was > 13% for at least five minutes. The primary outcome was to determine the serum lactate difference between preoperative and postoperative values, which could fairly predict fluid deficit leading to inadequate perfusion. A total of 74 patients were analysed. Both PVI- and PPV-guided GDFT strategies showed no significant difference in the postoperative lactate values, with a P-value of 0.18. Similarly, the mean total fluid administered, mean blood loss, length of CCU stay, and emetic and hypotension episodes also showed no significant differences among the groups with P-values of 0.41, 0.78, 0.25, 0.30, and 0.67, respectively. For patients undergoing neurosurgery (supratentorial ICSOLs), PVI seems to guide GDFT comparably to PPV regarding tissue perfusion and postoperative complications. However, both the parameters had low sensitivity and specificity, with an area of curve of 0.577 for PPV and 0.423 for PVI, as far as GDFT was concerned.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"30 1","pages":"18-25"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/ed/rjaic-30-1-rjaic-2023-0003.PMC10403147.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10007354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rectus Sheath Block in Abdominal Surgery: A Systematic Review with Meta-Analysis.","authors":"Yerkin Abdildin,&nbsp;Karina Tapinova,&nbsp;Azamat Salamat,&nbsp;Ramazan Shaimakhanov,&nbsp;Alisher Aitbayev,&nbsp;Dmitriy Viderman","doi":"10.2478/rjaic-2023-0006","DOIUrl":"https://doi.org/10.2478/rjaic-2023-0006","url":null,"abstract":"<p><strong>Background and aims: </strong>With the development of ultrasound-guided and laparoscopic techniques of rectus sheath block (RSB), regional analgesia promises to be efficient and safe. However, studies show controversial results. Our systematic review with meta-analysis aims to evaluate the effect of rectus sheath block in abdominal surgery.</p><p><strong>Method: </strong>We searched PubMed, Google Scholar, and the Cochrane Library from inception to October 2021 for randomised controlled trials written in English. We included studies on adult populations undergoing abdominal surgery. The primary outcomes of our meta-analysis were postoperative pain intensity and postoperative opioid consumption. Data analysis was conducted using the Review Manager software (RevMan, v. 5.4). Statistical heterogeneity was estimated by the I² statistic. The methodological quality of the included studies was assessed using the Oxford quality scoring system (Jadad Scale).</p><p><strong>Results: </strong>Eight randomised controlled trials (RCTs) in English with a total of 386 patients were included in this meta-analysis. Patients in the RSB group did not consume fewer anaesthetics and opioids after abdominal surgery when compared with patients in the control group. In addition, postoperative pain intensity (out of 10) was not lower in the RSB group when compared with the control group. Finally, RSB did not improve the time to the first opioid/analgesic (min) compared with the non-RSB option.</p><p><strong>Conclusion: </strong>There is no statistically significant evidence in favour of RSB over non-RSB in reducing anaesthetics and opioid consumption, postoperative pain intensity, and increasing time to first opioid/analgesic.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"30 1","pages":"43-50"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/42/98/rjaic-30-1-rjaic-2023-0006.PMC10448445.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10463585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antiemetic Efficacy of Palonosetron Compared with the Combination of Ondansetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gynaecological Surgery.","authors":"Samarjit Dey, Sairem Mangolnganbi Chanu, Priyanka Dev, Manas Borthakur, Habib Md Reazaul Karim, Md Yunus","doi":"10.2478/rjaic-2021-0003","DOIUrl":"10.2478/rjaic-2021-0003","url":null,"abstract":"<p><strong>Background and aims: </strong>For the prevention of PONV, we evaluated the efficacy of palonosetron compared with ondansetron along with dexamethasone in patients undergoing laparoscopic gynaecological surgery.</p><p><strong>Methods: </strong>A total of 84 adults, posted for elective laparoscopic surgeries under general anaesthesia were included in the study. The patients were randomly allocated to two groups (n = 42 each). Immediately after induction, patients in the first group (group I) received 4 mg ondansetron with 8 mg dexamethasone, and patients in the second group (group II) received 0.075 mg palonosetron. Any incidences of nausea and/or vomiting, the requirement of rescue antiemetic, and side effects were recorded.</p><p><strong>Results: </strong>In group I, 66.67% of the patients had an Apfel score of 2, and 33.33% of the patients had a score of 3. In group II, 85.71% of patients had an Apfel score of 2, and 14.29% of the patients had a score of 3. At 1, 4, and 8 hours, the incidence of PONV was comparable in both groups. At 24 hours there was a significant difference in the incidence of PONV in the group treated with ondansetron with dexamethasone combination (4/42) when compared to the palonosetron group (0/42). The overall incidence of PONV was significantly higher in group I (23.81%: ondansetron and dexamethasone combination) than in group II (7.14%: palonosetron). The need for rescue medication in group I was significantly high. Conclusion: Palonosetron was more efficacious compared to the combination of ondansetron and dexamethasone for preventing PONV for laparoscopic gynaecological surgery.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"28 1","pages":"19-24"},"PeriodicalIF":0.0,"publicationDate":"2022-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/ee/rjaic-28-019.PMC9949011.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10794838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pneumothorax in Critically Ill COVID-19 Patients in the Indian Subcontinent.","authors":"Anshul Singh","doi":"10.2478/rjaic-2022-0002","DOIUrl":"https://doi.org/10.2478/rjaic-2022-0002","url":null,"abstract":"<p><strong>Background and aims: </strong>To explore the incidence and risk factors, as well as mortality, in critically ill COVID-19 patients who developed pneumothorax (PTX) and/or pneumomediastinum (PNM).</p><p><strong>Methods: </strong>A retrospective cohort study was undertaken to analyse data of all patients with moderate to severe COVID-19 disease who were either RTPCR positive or had a clinico-radiological diagnosis. The exposure group consisted of COVID-19 patients who presented with PTX/PNM, whereas the non-exposure group consisted of patients who did not develop PTX and/or PNM during the stay.</p><p><strong>Results: </strong>Incidence of PTX/PNM was observed to be 1.9% among critically ill COVID-19 patients. 94.4% (17/18) of patients in the PTX group received positive pressure ventilation (PPV); the majority of these patients were on non-invasive ventilation when they developed PTX/PNM; only one patient was receiving conventional oxygen therapy. COVID-19 patients who developed PTX/PNM had 2.7 times higher mortality. A mortality rate of 72.2% was observed in COVID-19 patients who developed PTX/PNM.</p><p><strong>Conclusion: </strong>Development of PTX/PNM in critically ill COVID-19 patients is associated with more severe disease involvement, and institution of PPV is an additional risk factor. Significantly high mortality was observed following PTX/PNM in critically ill COVID-19 patients and is an independent marker of poor prognosis in COVID-19 disease.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"29 1","pages":"8-15"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/ac/rjaic-29-008.PMC9949014.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10799413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Tocilizumab on \"Ventilator Free Days\" Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis.","authors":"Ahmed F Mady,&nbsp;Basheer Abdulrahman,&nbsp;Shahzad A Mumtaz,&nbsp;Mohammed A Al-Odat,&nbsp;Ahmed Kuhail,&nbsp;Rehab Altoraifi,&nbsp;Rayan Alshae,&nbsp;Abdulrahman M Alharthy,&nbsp;Dimitrios Karakitsos,&nbsp;Waleed Th Aletreby","doi":"10.2478/rjaic-2022-0001","DOIUrl":"https://doi.org/10.2478/rjaic-2022-0001","url":null,"abstract":"<p><strong>Background: </strong>SARS-CoV-2 infection demonstrates a wide range of severity. More severe cases demonstrate a cytokine storm with elevated serum interleukin-6, hence IL-6 receptor antibody tocilizumab was tried for the management of severe cases.</p><p><strong>Aims: </strong>Effect of tocilizumab on ventilator-free days among critically ill SARS-CoV-2 patients.</p><p><strong>Method: </strong>Retrospective propensity score matching study, comparing mechanically ventilated patients who received tocilizumab to a control group.</p><p><strong>Results: </strong>29 patients in the intervention group were compared to 29 controls. Matched groups were similar. Ventilator-free days were more numerous in the intervention group (SHR 2.7, 95% CI: 1.2 - 6.3; p = 0.02), ICU mortality rate was not different (37.9% versus 62%, p = 0.1), actual ventilator-free periods were significantly longer in tocilizumab group (mean difference 4.7 days; p = 0.02). Sensitivity analysis showed a significantly lower hazard ratio of death in tocilizumab group (HR 0.49, 95% CI: 0.25 - 0.97; p = 0.04). There was no difference in positive cultures among groups (55.2% in tocilizumab group versus 34.5% in the control; p = 0.1).</p><p><strong>Conclusion: </strong>Tocilizumab may improve the composite outcome of ventilator-free days at day 28 among mechanically ventilated SARS-CoV-2 patients; it is associated with significantly longer actual ventilator-free periods, and insignificantly lower mortality and higher superinfection.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"29 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/96/rjaic-29-001.PMC9949015.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10789701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Comparative Study of Palonosetron with Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynaecological Surgeries.","authors":"Rohit Balyan,&nbsp;Sachin Kumar,&nbsp;K Lalitha,&nbsp;Sanjeev Aneja,&nbsp;Jai S George","doi":"10.2478/rjaic-2022-0005","DOIUrl":"https://doi.org/10.2478/rjaic-2022-0005","url":null,"abstract":"<p><strong>Background: </strong>Incidence of postoperative nausea and vomiting (PONV) in susceptible patients can be unacceptably high (70-80% reported incidence). This study was designed to evaluate the effect of palonosetron and ondansetron in preventing PONV in high-risk patients undergoing gynaecological laparoscopic surgery.</p><p><strong>Methodology: </strong>In this randomised, controlled, double-blind trial, nonsmoking females 18-70 years and weighing 40-90 kg, scheduled for elective laparoscopic gynaecological surgeries, were enrolled into the ondansetron (Group A, n=65) or palonosetron (Group B, n=65) group. Palonosetron (1 mcg/kg 4) or ondansetron (0.1 mg/kg 4) were administered just before induction. Postoperatively, incidence of nausea, vomiting, PONV (scored on a scale of 0-3), need for rescue antiemetic, complete response, patient satisfaction, and adverse effects were evaluated for up to 48 h following surgery.</p><p><strong>Results: </strong>The overall PONV scores and postoperative nausea score during 0-2 h and 24-48 h were comparable, but PONV scores (P=0.023) and postoperative nausea scores (P=0.010) during 2-24 h were significantly lesser in Group B compared to Group A. There was no statistically significant difference in the postoperative vomiting score or retching during 0-48 h. The amount of first-line rescue antiemetic used during 2-24 h was significantly higher in Group A (56%) than in Group B (31%) (P=0.012; P<0.05). Complete response to the drug during 2-24 h was significantly higher (P=0.023) in Group B (63%) compared to Group A (40%), whereas response was comparable during 0-2 h and 24-48 h. Both groups had comparable incidences of adverse effects and patient satisfaction scores.</p><p><strong>Conclusion: </strong>Palonosetron has superior antinausea effect, less need of rescue antiemetics, and lesser incidence of total PONV in comparison to ondansetron during 2-24 h and comparable effect to ondansetron during the 0-2 h and 24-48 h postoperative periods in high-risk patients undergoing gynaecological laparoscopic surgery.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"29 1","pages":"32-40"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/27/rjaic-29-032.PMC9949013.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10799418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Narrative Review on Perioperative Shivering during Caesarean Section under Neuraxial Anaesthesia.","authors":"Kamal Kumar,&nbsp;Cheng Lin,&nbsp;Tammy Symons,&nbsp;Craig Railton","doi":"10.2478/rjaic-2022-0006","DOIUrl":"https://doi.org/10.2478/rjaic-2022-0006","url":null,"abstract":"<p><p>Perioperative shivering is a well-known complication reported in 29 to 54% of patients undergoing a caesarean section under regional anaesthesia. It interferes with pulse oximetry, blood pressure (BP), and electrocardiographic monitoring (ECG). Moreover, it gives the patient a distressing and unpleasant experience. This review aims to examine the mechanism of shivering during the caesarean section under neuraxial anaesthesia and to explore available information for preventing and managing this clinically significant complication. A literature search of PubMed, MedLine, Science Direct, and Google Scholar was done. The search results were limited to randomised controlled trials (RCT) and systematic reviews. This review studied the efficacy of various nonpharmacological and pharmacological methods to manage perioperative shivering. We found that pre-warming and intraoperative warming are simple and effective interventions, although the effect seems to depend on the duration of treatment. Multiple pharmacological interventions, including opioids, NMDA receptor antagonists, and alpha-2 adrenergic agonists, have been studied and found to reduce the incidence and severity of perioperative shivering during caesarean section under neuraxial anaesthesia.</p>","PeriodicalId":21279,"journal":{"name":"Romanian journal of anaesthesia and intensive care","volume":"29 1","pages":"41-46"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/07/rjaic-29-041.PMC9949012.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10799414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}